Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal Mycophenolate Mofetil Blood Concentrations in Pediatric SRNS and Renal Transplantation
jRCT1031230722Recruiting
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of mycophenolate mofetil in nephrosis and Kidney allograft status (RTx) (2 arms), sponsored by none. Primary endpoint: Predicted AUC(0–12) of mycophenolic acid. Started Mar 2024; status: recruiting.
02
Drugs
mycophenolate mofetil
03
Conditions
nephrosisKidney allograft status (RTx)
Beyond the preview
Go deeper on jRCT1031230722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031230722.